Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan L Absalom

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Brain : a Journal of Neurology|August 30, 2023
Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severitySusan X N Lin, Philip K Ahring, Angelo Keramidas, et al.
Pharmacological Research|November 26, 2018
Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometryDinesh C Indurthi, Taima Qudah, Vivian W Liao, et al.
Biochemical Pharmacology|February 20, 2014
Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1Dinesh C Indurthi, Elena Pera, Hye-Lim Kim, et al.
Journal of Neurochemistry|August 25, 2023
GABA<sub>A</sub> receptors in epilepsy: Elucidating phenotypic divergence through functional analysis of genetic variantsNathan L Absalom, Susan X N Lin, Vivian W Y Liao, et al.
Plos One|June 23, 2016
Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular MechanismHan Chow Chua, Emilie T H Christensen, Kirsten Hoestgaard-Jensen, et al.
Neuropharmacology|October 30, 2020
The anticonvulsant zonisamide positively modulates recombinant and native glycine receptors at clinically relevant concentrationsSteven O Devenish, Bryony L Winters, Lyndsey L Anderson, et al.
Epilepsia|October 19, 2019
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactionsLyndsey L Anderson, Nathan L Absalom, Sarah V Abelev, et al.
The Journal of Biological Chemistry|July 30, 2013
Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealedNathan L Absalom, Gracia Quek, Trevor M Lewis, et al.
The Journal of Biological Chemistry|February 8, 2019
Functional genomics of epilepsy-associated mutations in the GABA<sub>A</sub> receptor subunits reveal that one mutation impairs function and two are catastrophicNathan L Absalom, Philip K Ahring, Vivian W Liao, et al.
Plos One|July 5, 2013
Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in miceMichelle Goldsworthy, Nathan L Absalom, David Schröter, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Brain : a Journal of Neurology|August 30, 2023
Correlations of receptor desensitization of gain-of-function GABRB3 variants with clinical severitySusan X N Lin, Philip K Ahring, Angelo Keramidas, et al.
Pharmacological Research|November 26, 2018
Revisiting autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE) mutations in the nicotinic acetylcholine receptor reveal an increase in efficacy regardless of stochiometryDinesh C Indurthi, Taima Qudah, Vivian W Liao, et al.
Biochemical Pharmacology|February 20, 2014
Presence of multiple binding sites on α9α10 nAChR receptors alludes to stoichiometric-dependent action of the α-conotoxin, Vc1.1Dinesh C Indurthi, Elena Pera, Hye-Lim Kim, et al.
Journal of Neurochemistry|August 25, 2023
GABA<sub>A</sub> receptors in epilepsy: Elucidating phenotypic divergence through functional analysis of genetic variantsNathan L Absalom, Susan X N Lin, Vivian W Y Liao, et al.
Plos One|June 23, 2016
Kavain, the Major Constituent of the Anxiolytic Kava Extract, Potentiates GABAA Receptors: Functional Characteristics and Molecular MechanismHan Chow Chua, Emilie T H Christensen, Kirsten Hoestgaard-Jensen, et al.
Neuropharmacology|October 30, 2020
The anticonvulsant zonisamide positively modulates recombinant and native glycine receptors at clinically relevant concentrationsSteven O Devenish, Bryony L Winters, Lyndsey L Anderson, et al.
Epilepsia|October 19, 2019
Coadministered cannabidiol and clobazam: Preclinical evidence for both pharmacodynamic and pharmacokinetic interactionsLyndsey L Anderson, Nathan L Absalom, Sarah V Abelev, et al.
The Journal of Biological Chemistry|July 30, 2013
Covalent trapping of methyllycaconitine at the α4-α4 interface of the α4β2 nicotinic acetylcholine receptor: antagonist binding site and mode of receptor inhibition revealedNathan L Absalom, Gracia Quek, Trevor M Lewis, et al.
The Journal of Biological Chemistry|February 8, 2019
Functional genomics of epilepsy-associated mutations in the GABA<sub>A</sub> receptor subunits reveal that one mutation impairs function and two are catastrophicNathan L Absalom, Philip K Ahring, Vivian W Liao, et al.
Plos One|July 5, 2013
Mutations in Mll2, an H3K4 methyltransferase, result in insulin resistance and impaired glucose tolerance in miceMichelle Goldsworthy, Nathan L Absalom, David Schröter, et al.
Pageof 3